Search

everythinglearnresearchcommunity

for

Search:↓

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

COVID-19 vaccination may lower vitamin D levels and cause hair loss.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Post-COVID-19 patients are at risk for hair loss.

Covid-19 worsens existing health issues and long-term effects are predictable.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.

BCG site reactions after COVID-19 mRNA vaccination are mild, temporary, and likely under-reported.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

Skin symptoms appear in up to 20% of Covid-19 cases.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.